The Clinical Trial Landscape for Melanoma Therapies
2019 · Journal of Clinical Medicine · 62 citations
https://doi.org/10.3390/jcm8030368
M
Małgorzata Przybyło
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.1K
Citations
23
h-index
33
i10-index
Małgorzata Przybyło is an academic researcher from Jagiellonian University. The author has contributed to research in topics: Glycosylation and Glycoproteins Research & Extracellular vesicles in disease & Cell Adhesion Molecules Research. The author has an h-index of 23, co-authored 63 publications.
ORCID: 0000-0001-9889-8522Papers by this author
worksExtracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications
2019 · Current Pharmaceutical Design · 49 citations
https://doi.org/10.2174/1381612825666190306153318
Human melanoma-derived ectosomes are enriched with specific glycan epitopes
2018 · Life Sciences · 46 citations
https://doi.org/10.1016/j.lfs.2018.06.026
Different glycosylation of cadherins from human bladder non-malignant and cancer cell lines
2002 · Cancer Cell International · 37 citations
https://doi.org/10.1186/1475-2867-2-6
On the trail of the glycan codes stored in cancer-related cell adhesion proteins
2016 · Biochimica et Biophysica Acta (BBA) - General Subjects · 29 citations
https://doi.org/10.1016/j.bbagen.2016.08.007
Melanoma-Derived Extracellular Vesicles: Focus on Their Proteome
2019 · Proteomes · 28 citations
https://doi.org/10.3390/proteomes7020021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat